Home » Topics » Regulatory » Patents

Patents
RSS

Antianginal and antiulcer agents from Sankyo

Nov. 8, 1996

Teijin discloses PDGF-inhibitory agents

Nov. 8, 1996

Natural dual inhibitor of ECE and NEP described by Sankyo

Nov. 8, 1996

Potential antihypertensive agents reported by Kyowa Hakko

Nov. 8, 1996

Warner-Lambert claims NK3 antagonists with broad therapeutic applications

Nov. 8, 1996

Taisho discloses agent for cerebrovascular disorders

Nov. 8, 1996

Mitsubishi reports cathepsin B/calpain inhibitors

Nov. 8, 1996

Histamine H3 receptor ligands described by INSERM/Bioprojet

Nov. 8, 1996

5-HT1A receptor agonists from Sankyo

Nov. 8, 1996

Yoshitomi describes compounds for anxiety and epilepsy

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...